JD.com raises $3.9 billion in 2020’s second-biggest IPO so far
JD.com, the second-largest online retailer in China, has raised $3.9 billion during its secondary listing on the Hong Kong Stock Exchange.
The company is pricing its IPO at HK$226 per share, HK$10 below the top end of its indicated range. JD.com already trades on the Nasdaq.
Shares will start trading in Hong Kong on Thursday 18th – the same day as the company holds its massive annual Anniversary Sale (known as 6.18). Last year JD.com reported sales of almost $30 billion – this week’s event will be a key test of demand as China continues to recover from lockdown and battles a fresh outbreak of Covid-19 cases.
The JD.com IPO follows a public offering by NetEase which raised $2.7 billion. Together the two tech giants have raised $6.6 billion – almost double what the rest of the Hong Kong IPOs have raised all year.
NetEase shares ended their first day of trading up 5.7%, closing HK$7 higher than its offer price of HK$123.
Hong Kong IPOs get a boost on US-China tensions
Increasing tensions between Washington and Beijing have helped stoke the Hong Kong IPO market recently. The US House of Representatives is considering a bill that would mandate US-listed Chinese companies to undergo financial audits, which could result in a number of companies being delisted.
This has prompted many companies whose shares are already traded in the US to seek a secondary listing in Hong Kong as a precaution.
NetEase acknowledged the impact that rising tensions could have in its IPO filings. Baidu founder and chairman, Robin Li, also acknowledged recently that his company could consider a secondary listing in Hong Kong if the US government tightens regulations surrounding Chinese firms.
More IPOs on the way
This could be the start of a reawakening for the IPO market in Hong Kong. China Bohai Bank Co is looking to raise over $2 billion, while both Smoore International Holdings and SK Biopharmaceuticals are expected to raise around $800 million.
Upcoming Hong Kong IPOs
- China Bohai Bank
- SK Biopharmaceuticals
- Hygeia Healthcare Holdings
- Kangji Medical Holdings
- Smore International Holdings
- Zhenro Services Group